Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. β
Go to Publication β
Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , |
|
|
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. β
Go to Publication β
Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , |
|
|
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. β
Go to Publication β
Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , |
|
|
The Impact in Intestines and Microbiota in BALB/c Mice Through Consumption of Milk Fermented by Potentially Probiotic Lacticaseibacillus casei SJRP38 and Limosilactobacillus fermentum SJRP43. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2023 Oct 5 Epub: 2023 Oct 5 Authors de Souza BMS , Guerra LHA , Varallo GR , Taboga SR , Penna ALB , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. β
Go to Publication β
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. β
Go to Publication β
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. β
Go to Publication β
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. β
Go to Publication β
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. β
Go to Publication β
Nutrients (Nutrients ) Vol: 15 Issue 9 Pages: Pub: 2023 May 6 Epub: 2023 May 6 Authors Ozen M , Piloquet H , Schaubeck M , |
|
|
Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. β
Go to Publication β
Nutrients (Nutrients ) Vol: 15 Issue 9 Pages: Pub: 2023 May 6 Epub: 2023 May 6 Authors Ozen M , Piloquet H , Schaubeck M , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. β
Go to Publication β
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. β
Go to Publication β
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 16 Issue 5 Pages: 1773-1789 Pub: 2024 Oct Epub: 2023 Aug 10 Authors da Silva JYP , do Nascimento HMA , de Albuquerque TMR , Sampaio KB , Dos Santos Lima M , Monteiro M , Leite IB , da Silva EF , do Nascimento YM , da Silva MS , Tavares JF , de Brito Alves JL , de Oliveira MEG , de Souza EL , |
|
|
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 16 Issue 5 Pages: 1773-1789 Pub: 2024 Oct Epub: 2023 Aug 10 Authors da Silva JYP , do Nascimento HMA , de Albuquerque TMR , Sampaio KB , Dos Santos Lima M , Monteiro M , Leite IB , da Silva EF , do Nascimento YM , da Silva MS , Tavares JF , de Brito Alves JL , de Oliveira MEG , de Souza EL , |
|
|
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 16 Issue 5 Pages: 1773-1789 Pub: 2024 Oct Epub: 2023 Aug 10 Authors da Silva JYP , do Nascimento HMA , de Albuquerque TMR , Sampaio KB , Dos Santos Lima M , Monteiro M , Leite IB , da Silva EF , do Nascimento YM , da Silva MS , Tavares JF , de Brito Alves JL , de Oliveira MEG , de Souza EL , |
|
|
In vitro digestion and human gut microbiota fermentation of longan pulp polysaccharides as affected by Lactobacillus fermentum fermentation. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 147 Issue Pages: 363-368 Pub: 2020 Mar 15 Epub: 2020 Jan 7 Authors Huang F , Hong R , Yi Y , Bai Y , Dong L , Jia X , Zhang R , Wang G , Zhang M , Wu J , |
|
|
Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis. β
Go to Publication β
Frontiers in molecular biosciences (Front Mol Biosci ) Vol: 6 Issue Pages: 92 Pub: 2019 Epub: 2019 Sep 27 Authors Kim WK , Jang YJ , Han DH , Seo B , Park S , Lee CH , Ko G , |
|
|
In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation. β
Go to Publication β
Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 100 Issue 2 Pages: 705-713 Pub: 2020 Jan 30 Epub: 2019 Nov 9 Authors Thumu SCR , Halami PM , |
|
|
Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. β
Go to Publication β
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 33 Issue 9 Pages: 10005-10018 Pub: 2019 Sep Epub: 2019 Jun 7 Authors Toral M , Robles-Vera I , Romero M , de la Visitación N , Sánchez M , O'Valle F , Rodriguez-Nogales A , Gálvez J , Duarte J , Jiménez R , |
|
|
Lactobacillus fermentum CRL1446 Ameliorates Oxidative and Metabolic Parameters by Increasing Intestinal Feruloyl Esterase Activity and Modulating Microbiota in Caloric-Restricted Mice. β
Go to Publication β
Nutrients (Nutrients ) Vol: 8 Issue 7 Pages: Pub: 2016 Jul 7 Epub: 2016 Jul 7 Authors Russo M , Fabersani E , Abeijón-Mukdsi MC , Ross R , Fontana C , Benítez-Páez A , Gauffin-Cano P , Medina RB , |
|
|
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , |
|
|
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , |
|
|
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. β
Go to Publication β
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. β
Go to Publication β
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in Mice. β
Go to Publication β
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 35 Issue Pages: e2410009 Pub: 2024 Dec 10 Epub: 2024 Dec 10 Authors Joung JY , Choi K , Lee JH , Oh NS , |
|
|
Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in Mice. β
Go to Publication β
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 35 Issue Pages: e2410009 Pub: 2024 Dec 10 Epub: 2024 Dec 10 Authors Joung JY , Choi K , Lee JH , Oh NS , |
|
|
Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in Mice. β
Go to Publication β
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 35 Issue Pages: e2410009 Pub: 2024 Dec 10 Epub: 2024 Dec 10 Authors Joung JY , Choi K , Lee JH , Oh NS , |
|
|
Limosilactobacillus Fermentun ZS09 Can Improve Antibiotic-Induced Motor Dysfunction in Mice by Regulating the Brain-Gut Functions. β
Go to Publication β
Journal of inflammation research (J Inflamm Res ) Vol: 17 Issue Pages: 10093-10106 Pub: 2024 Epub: 2024 Nov 30 Authors Yang Y , Zhao Y , Lei H , Tan X , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. β
Go to Publication β
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
